IBDEI0Q0 ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34432,2)
 ;;=^5003037
 ;;^UTILITY(U,$J,358.3,34433,0)
 ;;=E89.6^^100^1499^47
 ;;^UTILITY(U,$J,358.3,34433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34433,1,3,0)
 ;;=3^PostProcedural Adrenocortical Hypofunction
 ;;^UTILITY(U,$J,358.3,34433,1,4,0)
 ;;=4^E89.6
 ;;^UTILITY(U,$J,358.3,34433,2)
 ;;=^5003042
 ;;^UTILITY(U,$J,358.3,34434,0)
 ;;=L68.0^^100^1499^25
 ;;^UTILITY(U,$J,358.3,34434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34434,1,3,0)
 ;;=3^Hirsutism
 ;;^UTILITY(U,$J,358.3,34434,1,4,0)
 ;;=4^L68.0
 ;;^UTILITY(U,$J,358.3,34434,2)
 ;;=^5009262
 ;;^UTILITY(U,$J,358.3,34435,0)
 ;;=M80.00XA^^100^1499^2
 ;;^UTILITY(U,$J,358.3,34435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34435,1,3,0)
 ;;=3^Age-Related Osteoporosis w/ Fx,Unspec Site,Init Encntr
 ;;^UTILITY(U,$J,358.3,34435,1,4,0)
 ;;=4^M80.00XA
 ;;^UTILITY(U,$J,358.3,34435,2)
 ;;=^5013363
 ;;^UTILITY(U,$J,358.3,34436,0)
 ;;=M81.0^^100^1499^3
 ;;^UTILITY(U,$J,358.3,34436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34436,1,3,0)
 ;;=3^Age-Related Osteoporosis w/o Fx
 ;;^UTILITY(U,$J,358.3,34436,1,4,0)
 ;;=4^M81.0
 ;;^UTILITY(U,$J,358.3,34436,2)
 ;;=^5013555
 ;;^UTILITY(U,$J,358.3,34437,0)
 ;;=M85.80^^100^1499^44
 ;;^UTILITY(U,$J,358.3,34437,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34437,1,3,0)
 ;;=3^Osteopenia,Unspec Site
 ;;^UTILITY(U,$J,358.3,34437,1,4,0)
 ;;=4^M85.80
 ;;^UTILITY(U,$J,358.3,34437,2)
 ;;=^5014473
 ;;^UTILITY(U,$J,358.3,34438,0)
 ;;=N62.^^100^1499^24
 ;;^UTILITY(U,$J,358.3,34438,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34438,1,3,0)
 ;;=3^Gynecomastia
 ;;^UTILITY(U,$J,358.3,34438,1,4,0)
 ;;=4^N62.
 ;;^UTILITY(U,$J,358.3,34438,2)
 ;;=^5015790
 ;;^UTILITY(U,$J,358.3,34439,0)
 ;;=E10.43^^100^1499^6
 ;;^UTILITY(U,$J,358.3,34439,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34439,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,34439,1,4,0)
 ;;=4^E10.43
 ;;^UTILITY(U,$J,358.3,34439,2)
 ;;=^5002607
 ;;^UTILITY(U,$J,358.3,34440,0)
 ;;=E10.59^^100^1499^4
 ;;^UTILITY(U,$J,358.3,34440,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34440,1,3,0)
 ;;=3^DM Type 1 w/ Circulatory Complications
 ;;^UTILITY(U,$J,358.3,34440,1,4,0)
 ;;=4^E10.59
 ;;^UTILITY(U,$J,358.3,34440,2)
 ;;=^5002612
 ;;^UTILITY(U,$J,358.3,34441,0)
 ;;=E10.618^^100^1499^5
 ;;^UTILITY(U,$J,358.3,34441,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34441,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Arthropathy
 ;;^UTILITY(U,$J,358.3,34441,1,4,0)
 ;;=4^E10.618
 ;;^UTILITY(U,$J,358.3,34441,2)
 ;;=^5002614
 ;;^UTILITY(U,$J,358.3,34442,0)
 ;;=E10.621^^100^1499^7
 ;;^UTILITY(U,$J,358.3,34442,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34442,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,34442,1,4,0)
 ;;=4^E10.621
 ;;^UTILITY(U,$J,358.3,34442,2)
 ;;=^5002616
 ;;^UTILITY(U,$J,358.3,34443,0)
 ;;=E10.622^^100^1499^11
 ;;^UTILITY(U,$J,358.3,34443,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34443,1,3,0)
 ;;=3^DM Type 1 w/ Skin Ulcer
 ;;^UTILITY(U,$J,358.3,34443,1,4,0)
 ;;=4^E10.622
 ;;^UTILITY(U,$J,358.3,34443,2)
 ;;=^5002617
 ;;^UTILITY(U,$J,358.3,34444,0)
 ;;=E10.65^^100^1499^10
 ;;^UTILITY(U,$J,358.3,34444,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34444,1,3,0)
 ;;=3^DM Type 1 w/ Hyperglycermia
 ;;^UTILITY(U,$J,358.3,34444,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,34444,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,34445,0)
 ;;=E10.39^^100^1499^9
 ;;^UTILITY(U,$J,358.3,34445,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34445,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Ophthalmic Complications NEC
 ;;^UTILITY(U,$J,358.3,34445,1,4,0)
 ;;=4^E10.39
 ;;^UTILITY(U,$J,358.3,34445,2)
 ;;=^5002603
 ;;^UTILITY(U,$J,358.3,34446,0)
 ;;=E66.3^^100^1499^45
 ;;^UTILITY(U,$J,358.3,34446,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34446,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,34446,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,34446,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,34447,0)
 ;;=E89.1^^100^1499^49
 ;;^UTILITY(U,$J,358.3,34447,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34447,1,3,0)
 ;;=3^Postprocedural Hypoinsulinemia
 ;;^UTILITY(U,$J,358.3,34447,1,4,0)
 ;;=4^E89.1
 ;;^UTILITY(U,$J,358.3,34447,2)
 ;;=^5003036
 ;;^UTILITY(U,$J,358.3,34448,0)
 ;;=H40.9^^100^1500^9
 ;;^UTILITY(U,$J,358.3,34448,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34448,1,3,0)
 ;;=3^Glaucoma,Unspec
 ;;^UTILITY(U,$J,358.3,34448,1,4,0)
 ;;=4^H40.9
 ;;^UTILITY(U,$J,358.3,34448,2)
 ;;=^5005931
 ;;^UTILITY(U,$J,358.3,34449,0)
 ;;=H26.9^^100^1500^5
 ;;^UTILITY(U,$J,358.3,34449,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34449,1,3,0)
 ;;=3^Cataract,Unspec
 ;;^UTILITY(U,$J,358.3,34449,1,4,0)
 ;;=4^H26.9
 ;;^UTILITY(U,$J,358.3,34449,2)
 ;;=^5005363
 ;;^UTILITY(U,$J,358.3,34450,0)
 ;;=H10.9^^100^1500^8
 ;;^UTILITY(U,$J,358.3,34450,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34450,1,3,0)
 ;;=3^Conjunctivitis,Unspec
 ;;^UTILITY(U,$J,358.3,34450,1,4,0)
 ;;=4^H10.9
 ;;^UTILITY(U,$J,358.3,34450,2)
 ;;=^5004716
 ;;^UTILITY(U,$J,358.3,34451,0)
 ;;=H11.32^^100^1500^6
 ;;^UTILITY(U,$J,358.3,34451,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34451,1,3,0)
 ;;=3^Conjunctival Hemorrhage,Left Eye
 ;;^UTILITY(U,$J,358.3,34451,1,4,0)
 ;;=4^H11.32
 ;;^UTILITY(U,$J,358.3,34451,2)
 ;;=^5004783
 ;;^UTILITY(U,$J,358.3,34452,0)
 ;;=H11.31^^100^1500^7
 ;;^UTILITY(U,$J,358.3,34452,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34452,1,3,0)
 ;;=3^Conjunctival Hemorrhage,Right Eye
 ;;^UTILITY(U,$J,358.3,34452,1,4,0)
 ;;=4^H11.31
 ;;^UTILITY(U,$J,358.3,34452,2)
 ;;=^5004782
 ;;^UTILITY(U,$J,358.3,34453,0)
 ;;=H01.002^^100^1500^3
 ;;^UTILITY(U,$J,358.3,34453,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34453,1,3,0)
 ;;=3^Blepharitis Unspec,Right Lower Eyelid
 ;;^UTILITY(U,$J,358.3,34453,1,4,0)
 ;;=4^H01.002
 ;;^UTILITY(U,$J,358.3,34453,2)
 ;;=^5004239
 ;;^UTILITY(U,$J,358.3,34454,0)
 ;;=H01.004^^100^1500^2
 ;;^UTILITY(U,$J,358.3,34454,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34454,1,3,0)
 ;;=3^Blepharitis Unspec,Left Upper Eyelid
 ;;^UTILITY(U,$J,358.3,34454,1,4,0)
 ;;=4^H01.004
 ;;^UTILITY(U,$J,358.3,34454,2)
 ;;=^5004241
 ;;^UTILITY(U,$J,358.3,34455,0)
 ;;=H01.005^^100^1500^1
 ;;^UTILITY(U,$J,358.3,34455,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34455,1,3,0)
 ;;=3^Blepharitis Unspec,Left Lower Eyelid
 ;;^UTILITY(U,$J,358.3,34455,1,4,0)
 ;;=4^H01.005
 ;;^UTILITY(U,$J,358.3,34455,2)
 ;;=^5133380
 ;;^UTILITY(U,$J,358.3,34456,0)
 ;;=H01.001^^100^1500^4
 ;;^UTILITY(U,$J,358.3,34456,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34456,1,3,0)
 ;;=3^Blepharitis Unspec,Right Upper Eyelid
 ;;^UTILITY(U,$J,358.3,34456,1,4,0)
 ;;=4^H01.001
 ;;^UTILITY(U,$J,358.3,34456,2)
 ;;=^5004238
 ;;^UTILITY(U,$J,358.3,34457,0)
 ;;=H57.13^^100^1500^10
 ;;^UTILITY(U,$J,358.3,34457,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34457,1,3,0)
 ;;=3^Ocular Pain,Bilateral
 ;;^UTILITY(U,$J,358.3,34457,1,4,0)
 ;;=4^H57.13
 ;;^UTILITY(U,$J,358.3,34457,2)
 ;;=^5006384
 ;;^UTILITY(U,$J,358.3,34458,0)
 ;;=H57.12^^100^1500^11
 ;;^UTILITY(U,$J,358.3,34458,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34458,1,3,0)
 ;;=3^Ocular Pain,Left Eye
 ;;^UTILITY(U,$J,358.3,34458,1,4,0)
 ;;=4^H57.12
 ;;^UTILITY(U,$J,358.3,34458,2)
 ;;=^5006383
 ;;^UTILITY(U,$J,358.3,34459,0)
 ;;=H57.11^^100^1500^12
 ;;^UTILITY(U,$J,358.3,34459,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34459,1,3,0)
 ;;=3^Ocular Pain,Right Eye
 ;;^UTILITY(U,$J,358.3,34459,1,4,0)
 ;;=4^H57.11
 ;;^UTILITY(U,$J,358.3,34459,2)
 ;;=^5006382
 ;;^UTILITY(U,$J,358.3,34460,0)
 ;;=S05.02XA^^100^1501^3
 ;;^UTILITY(U,$J,358.3,34460,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34460,1,3,0)
 ;;=3^Inj Conjunctiva/Corneal Abrasion w/o FB,Left Eye,Init
 ;;^UTILITY(U,$J,358.3,34460,1,4,0)
 ;;=4^S05.02XA
 ;;^UTILITY(U,$J,358.3,34460,2)
 ;;=^5020582
 ;;^UTILITY(U,$J,358.3,34461,0)
 ;;=S05.01XA^^100^1501^4
 ;;^UTILITY(U,$J,358.3,34461,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34461,1,3,0)
 ;;=3^Inj Conjunctiva/Corneal Abrasion w/o FB,Right Eye,Init
 ;;^UTILITY(U,$J,358.3,34461,1,4,0)
 ;;=4^S05.01XA
 ;;^UTILITY(U,$J,358.3,34461,2)
 ;;=^5020579
 ;;^UTILITY(U,$J,358.3,34462,0)
 ;;=T15.02XA^^100^1501^1
 ;;^UTILITY(U,$J,358.3,34462,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34462,1,3,0)
 ;;=3^Foreign Body in Cornea,Left Eye,Init Encntr
 ;;^UTILITY(U,$J,358.3,34462,1,4,0)
 ;;=4^T15.02XA
 ;;^UTILITY(U,$J,358.3,34462,2)
 ;;=^5046387
 ;;^UTILITY(U,$J,358.3,34463,0)
 ;;=T15.01XA^^100^1501^2
 ;;^UTILITY(U,$J,358.3,34463,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34463,1,3,0)
 ;;=3^Foreign Body in Cornea,Right Eye,Init Encntr
 ;;^UTILITY(U,$J,358.3,34463,1,4,0)
 ;;=4^T15.01XA
 ;;^UTILITY(U,$J,358.3,34463,2)
 ;;=^5046384
 ;;^UTILITY(U,$J,358.3,34464,0)
 ;;=S00.252A^^100^1501^5
 ;;^UTILITY(U,$J,358.3,34464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34464,1,3,0)
 ;;=3^Superficial FB of Left Eyelid/Periocular Area,Init Encntr
 ;;^UTILITY(U,$J,358.3,34464,1,4,0)
 ;;=4^S00.252A
 ;;^UTILITY(U,$J,358.3,34464,2)
 ;;=^5019820
 ;;^UTILITY(U,$J,358.3,34465,0)
 ;;=S00.251A^^100^1501^6
 ;;^UTILITY(U,$J,358.3,34465,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34465,1,3,0)
 ;;=3^Superficial FB of Right Eyelid/Periocular Area,Init Encntr
 ;;^UTILITY(U,$J,358.3,34465,1,4,0)
 ;;=4^S00.251A
 ;;^UTILITY(U,$J,358.3,34465,2)
 ;;=^5019817
 ;;^UTILITY(U,$J,358.3,34466,0)
 ;;=B96.81^^100^1502^56
 ;;^UTILITY(U,$J,358.3,34466,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34466,1,3,0)
 ;;=3^H. Pylori as the Cause of Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,34466,1,4,0)
 ;;=4^B96.81
 ;;^UTILITY(U,$J,358.3,34466,2)
 ;;=^5000857
 ;;^UTILITY(U,$J,358.3,34467,0)
 ;;=B15.9^^100^1502^58
 ;;^UTILITY(U,$J,358.3,34467,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34467,1,3,0)
 ;;=3^Hepatitis A,Acute w/o Hepatic Coma
 ;;^UTILITY(U,$J,358.3,34467,1,4,0)
 ;;=4^B15.9
 ;;^UTILITY(U,$J,358.3,34467,2)
 ;;=^5000536
